Sign in

CIK 0001787740 · <br>Emerging growth company

Valion Bio, Inc.

Sign in to watch
Ticker
VBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
814016391
Phone
(888)276-6888
Business address
1305 E. HOUSTON STREET, BUILDING 1, SUITE 311, SAN ANTONIO, TX, 78205
Former names
Tivic Health Systems, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-02-04 Gurfein Blake Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +35,000 35,000
2021-12-14 Drexler Karen Director Grant or award · Employee Stock Option (Right to Buy) +18,000 18,000
2021-12-14 Gurfein Blake Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +82,500 82,500
2021-12-14 Zikria Dean Director Grant or award · Employee Stock Option (Right to Buy) +18,000 18,000
2021-12-14 Sabia Ryan VP of Sales and Operations Grant or award · Employee Stock Option (Right to Buy) +25,000 25,000
2021-12-14 Bolton Sheryle Director Grant or award · Employee Stock Option (Right to Buy) +18,000 18,000
2021-11-12 Ernst Jennifer Chief Executive Officer Conversion +1,391 1,172,891
2021-11-12 Ernst Jennifer Chief Executive Officer Conversion +26,986 1,199,877
2021-11-12 Ernst Jennifer Chief Executive Officer Conversion · Series Seed-2 Convertible Preferred Stock −5,566 0
2021-11-12 Ernst Jennifer Chief Executive Officer Conversion · Convertible Promissory Note −0 0

Page 4 of 4 · 70 trades